Swedencare Ab · OMXSTO:SECARE
Swedencare Ab — Q1 2022 Earnings Presentation
16 slides from Swedencare Ab's earnings presentation, March 2022
Slide 1: Q1 Interim Report January – March 2022
Q1 INTERIM REPORT January – March 2022 Presentation CEO Håkan Lagerberg CFO Jenny Graflind
Slide 2: Q1 2022 Highlights
Q1 2022 Highlights 2 new acquisitions & Strong start of the year New acquisitions – NaturVet & Innovet Organic growth 7% - 2022 target 20% New product launches from many brands Several Expos in Europe and USA Business development – Wide offering
Slide 3: Operational Net Sales and EBITDA
Operational Net sales (MSEK) EBITDA (MSEK) 400 100 350 90 300 80 2% 70 250 18 8% 60 15 200 50 150 40 30 100 20 134,0 377,7 36,7 94,7 50 10 27,4% 24,9% 0 - Q1 2021 Q1 2022 Q1 2021 Q1 2022
Slide 4: Key Performance Indicators Q1 2022
Key Performance Indicators Q1 2022
Slide 5: Sales per region Q1
Sales per region Q1 REST OF THE WORLD. REST OF THE WORLD UK/IRELAND 21% UK/IRELAND sew % 1 0% ve % 1% DYN REST OF EUROPE 6% 2 6% REST OF EUROPE 8% Q1 2022 NORTH AMERICA NORTH AMERICA __~ a 81% 63% ~~ 2 SWEDENCARE
Slide 6: Net Sales by region (MSEK): North America
- Several strategic discussions, both branded Net Sales by region (MSEK) and PL - Strong online growth, Pet MD, RX, PO and 81% of total sales NaturVet North America - 27% growth of PO-sales in North America 350 - Launching Dr. Pol on many online platforms, 300 including AZN Canada - Building organiz
Slide 7: Net Sales by region (MSEK): Europe
Net Sales by region (MSEK) 16% of total sales - Exceptional growth with Nutravet Europe including preparations to launch in 70 Scandinavia and more markets 60 - Growth comparison impacted by 50 % extraordinary deliveries in Q1 2021 56 - Irish Production strong numbers for 40 both internal and extern
Slide 8: Net Sales by region (MSEK): Asia & Rest of the world
Net Sales by region (MSEK) 3% of total sales Asia & Rest of the world - No delivery to China in Q1 9,6 - Non-organic exports better 9,4 9,2 - Introducing PO Powder to Japan Pet 9,0 retail, previously only in Vet - Brazilian Food project now in over -13 8,8 % 8,6 300 stores 8,4 - Strong markets: Japa
Slide 9: Sales per product category Q1
Sales per product category Q1
Slide 10: Rolling 4 Quarters
Rolling 4 Quarters 248 261 220 000 1 000 000 ) 900 000 180 000 800 000 700 000 140 000 600 000 120 000 500 000 100 000 400 000 80 000 800 000 60 000 200 000 |." ¥ 40 000 100 000 20 000 0 Qi Q2 Q38 O4 Qi Q2 28 A at Q2 QB 4 a 2019 2020 2021 2022 (Net revenue GM EBITDA 1) Operational EBITDA #8 SWEDENCA
Slide 11: Recent Acquisitions
Recent Acquisitions • Pet/Online with partners • Vet • +15’ Pet shops • 90% of sales in Italy • #1 Pet supplement brand in 4 of top 5 pet chains • Scientific innovation (own R&D) with patent in US protected products • Nutraceuticals & in-house leading manufacturing • Nutraceuticals • Sales 2021: 63,
Slide 12: Additions to Group Management
Additions to Group Management John Kane – CEO Vetio Brian Nugent – CEO Stratford Group Production Director COO North America – Vet- and online
Slide 13: Vision Mission
Vision Our vision is to establish ourselves as the leading company within Pet Health Care on all larger markets. Mission We care about improving the health and wellbeing of pets, creating reassurance for the pet parents, worldwide and throughout life.
Slide 14: Priorities 2022
Priorities 2022 Integration of acquired companies Increased Marketing Brand and Product development Prioritizing efforts on strategic partners Organization & adding talent M&A opportunities
Slide 15: Q&A
Q&A 1. Tell us more about the ongoing integration of NaturVet and Innovet into the group and what is the focus? 2. What is the status of China and Asia – There was no delivery in Q1 to China, are you worried? 3. You seem confident that the second half of 2022 will be better than the first half, plea
Slide 16: See you soon!
Live Chat starts in 5 min – See you soon!